Douglas Miehm
Stock Analyst at RBC Capital
(3.87)
# 1,810
Out of 4,382 analysts
389
Total ratings
50.2%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by Douglas Miehm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: DHT.UN DRI Healthcare Trust | Maintained: Buy | $21.00 | $18.32 | +14.63% | 41 | May 15, 2026 | |
| TSX: DR Medical Facilities Corporation | Maintained: Hold | $17.00 → $19.00 | $18.51 | +2.65% | 46 | May 10, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | $7.00 | $4.84 | +44.63% | 22 | May 10, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Hold | $15 | $15.84 | -5.30% | 43 | May 8, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $8.50 → $9.50 | $8.61 | +10.34% | 27 | May 8, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $235 → $262 | $237.00 | +10.55% | 16 | May 7, 2026 | |
| MNKD MannKind | Maintained: Hold | $3.5 → $4.75 | $3.40 | +39.71% | 8 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $22 → $24 | $22.75 | +5.49% | 5 | Apr 30, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | $12.54 | $7.49 | +67.43% | 102 | Apr 30, 2026 | |
| BLCO Bausch + Lomb | Maintained: Buy | $21 | $15.46 | +35.83% | 36 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.89 | $14.19 | -44.36% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.51 → $3.5 | $0.8362 | +318.56% | 30 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $4.94 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.00 | $87.85 | n/a | 3 | Jun 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $5.13 | n/a | 6 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $2.56 | n/a | 1 | Feb 5, 2009 |
DRI Healthcare Trust
May 15, 2026
Maintained: Buy
Price Target: $21.00
Current: $18.32
Upside: +14.63%
Medical Facilities Corporation
May 10, 2026
Maintained: Hold
Price Target: $17.00 → $19.00
Current: $18.51
Upside: +2.65%
WELL Health Technologies Corp.
May 10, 2026
Reiterated: Buy
Price Target: $7.00
Current: $4.84
Upside: +44.63%
Aurinia Pharmaceuticals
May 8, 2026
Reiterated: Hold
Price Target: $15
Current: $15.84
Upside: -5.30%
Knight Therapeutics Inc.
May 8, 2026
Maintained: Buy
Price Target: $8.50 → $9.50
Current: $8.61
Upside: +10.34%
Ligand Pharmaceuticals
May 7, 2026
Reiterated: Buy
Price Target: $235 → $262
Current: $237.00
Upside: +10.55%
MannKind
May 7, 2026
Maintained: Hold
Price Target: $3.5 → $4.75
Current: $3.40
Upside: +39.71%
Pacira BioSciences
Apr 30, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $22.75
Upside: +5.49%
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: $12.54
Current: $7.49
Upside: +67.43%
Bausch + Lomb
Apr 30, 2026
Maintained: Buy
Price Target: $21
Current: $15.46
Upside: +35.83%
Mar 19, 2026
Maintained: Buy
Price Target: $7.89
Current: $14.19
Upside: -44.36%
Nov 19, 2025
Maintained: Buy
Price Target: $2.51 → $3.5
Current: $0.8362
Upside: +318.56%
Oct 8, 2021
Reiterated: Hold
Price Target: $18 → $19
Current: $4.94
Upside: n/a
Jun 23, 2021
Maintained: Buy
Price Target: €22.00
Current: $87.85
Upside: n/a
Aug 4, 2016
Reiterated: Hold
Price Target: $1
Current: $5.13
Upside: n/a
Feb 5, 2009
Upgraded: Buy
Price Target: n/a
Current: $2.56
Upside: n/a